One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome
To access this article, please choose from the options below
PII: S1389-9457(08)00148-2
doi:10.1016/j.sleep.2008.04.012
© 2008 Elsevier B.V. All rights reserved.
